This is a rare inherited condition that affects your eyes, skin, and blood cells. It causes a type of albinism (lack of pigment in the skin, hair, and eyes) and a problem with platelets (small blood cells that help with clotting). This leads to easy bruising and bleeding.
Every report comes from a Lived member, sent anonymously.
Have you tried DDAVP (Desmopressin) for Hermanski-Pudlak Syndrome?
Hermansky-Pudlak syndrome (HPS) is a rare inherited condition that affects pigment, blood clotting and, in some types, the lungs, bowel or immune system. Most people with HPS have oculocutaneous albinism, meaning reduced pigment in the skin, hair and eyes. Skin is usually at least a shade lighter than that of other family members, and hair can range from white to brown. The reduced eye pigment affects vision. Many people have nystagmus (involuntary, rapid eye movements), sensitivity to light, crossed or misaligned eyes, and reduced sharpness of vision. In HPS these vision problems usually stay stable after early childhood. What separates HPS from other forms of albinism is a bleeding tendency. Platelets, the blood cells that clump together to plug a cut, do not work properly, so people bruise easily and may have nosebleeds, bleeding gums, heavy periods or prolonged bleeding after dental work or surgery. Some types also cause pulmonary fibrosis (scarring of the lungs), which is the most serious complication of the condition.
HPS is caused by changes (variants) in one of at least 11 genes. These genes help build tiny specialized compartments inside certain cells: the pigment-making cells of the skin and eyes, platelets and some lung cells. When those compartments do not form or work properly, pigment is not made and distributed normally, platelets cannot release the substances they need to form a clot, and in some types lung tissue gradually scars. HPS is inherited in an autosomal recessive pattern. A person has HPS when they inherit a non-working copy of the same gene from each parent. Parents who each carry one copy usually have no symptoms, and each of their children has a 1 in 4 chance of having HPS. The gene involved shapes what HPS looks like. Types 1 and 4 are the most severe, and types 1, 2 and 4 are the only types linked to lung fibrosis. Types 3, 5 and 6 are milder, sometimes with little visible albinism. Type 2 and a related type can also weaken the immune system. HPS is very rare in most populations, but type 1 is common in northwestern Puerto Rico, where about 1 in 1,800 people are affected.
HPS is often first suspected in a child with albinism, especially one who bruises or bleeds easily. Because albinism by itself does not cause bleeding, that combination is an important clue. The defining test looks at platelets under an electron microscope. Normal platelets contain small storage granules called dense bodies; in HPS they are absent. Genetic testing can identify the specific gene involved, which confirms the diagnosis when features are unclear and, importantly, tells the care team which complications to watch for. After diagnosis, an eye examination, a skin check and, for types linked to lung disease, breathing tests help set a starting point for follow-up.
There is currently no cure for HPS. Treatment protects against its main problems: bleeding, sun damage, vision difficulties and, in some types, lung, bowel and immune complications. Care is usually coordinated by several specialists. Preventing bleeding is an everyday part of care. People with HPS are advised to avoid aspirin and over-the-counter anti-inflammatory pain relievers such as ibuprofen and naproxen, as well as blood thinners, unless a clinician specifically recommends them. Before surgery, tooth extraction or childbirth, the care team plans ahead. Desmopressin, a medicine that can temporarily improve clotting in some people, may be used, though responses vary a lot, so it is often tested beforehand. Platelet transfusions are used for major surgery or bleeding that does not stop. Hormonal birth control or a hormonal IUD (intrauterine device) can reduce heavy periods. Carrying a medical alert card or bracelet and a written bleeding plan helps in an unfamiliar setting. Vaccination against hepatitis A and B is recommended because blood products may be needed. The skin needs consistent protection from the sun, using clothing, hats and sunscreen, because sun damage and skin cancer are more likely. Glasses, low-vision aids, sunglasses that block ultraviolet light and school or workplace adjustments help with vision, and surgery can correct misaligned eyes. For types linked to lung fibrosis, protecting the lungs matters from a young age: no smoking or vaping, avoiding dust and fumes, staying up to date with flu, pneumonia and COVID-19 vaccines, treating chest infections promptly and exercising regularly. No medicine is approved specifically for HPS lung fibrosis. Pirfenidone, an antifibrotic drug used for other lung scarring, has given inconclusive results in HPS trials and is considered case by case. Oxygen helps in later stages, and lung transplantation is the established option for advanced disease, although bleeding risk adds to its difficulty. Colitis is treated much like Crohn's disease, with anti-inflammatory and immune-suppressing medicines, including biologic drugs such as infliximab for severe cases. People with immune weakness may need medicines that boost white blood cells and a plan to prevent infection.
HPS is lifelong, and its course depends heavily on the type. People with milder types may mainly live with easy bruising, the need for planning around procedures and, in some cases, low vision. Low vision affects reading, schoolwork and tasks such as driving, and aids, seating near the front in class and workplace adjustments make a real difference. For types 1, 2 and 4, lung fibrosis is the major concern. Symptoms such as breathlessness typically begin in the early 30s and can worsen over about a decade, sometimes leading to death, though the pace varies. Annual breathing tests from adolescence or early adulthood help detect changes early and allow time to plan, including discussions about transplant referral. Regular follow-up usually includes a yearly eye examination, a yearly skin check for sun damage or early skin cancer and, for at-risk types, yearly lung function testing. Relatives can be tested once the family's gene change is known, which matters most in milder types that may otherwise go unrecognized. Genetic counseling helps families understand the chances for future children.
Arrange an evaluation if a child or adult with albinism bruises easily or has unusual bleeding, or if HPS runs in the family. Before any surgery, dental extraction or planned delivery, contact the care team well ahead to arrange a bleeding plan. Contact the care team promptly about new shortness of breath, a dry cough that does not go away, a new or changing skin spot, or bowel symptoms such as cramping, mucus, blood in the stool or black stools. Bleeding that will not stop with firm pressure, or heavy bleeding after an injury, procedure or childbirth, needs urgent medical care. Bring or show the bleeding plan or medical alert information so staff know about HPS.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hermanski-Pudlak Syndrome is like, what's helped you, or ask the community a question.